MIRA Pharmaceuticals, Inc.
MIRA
$0.96
-$0.01-1.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -425.91% | 26.01% | 13.80% | 25.67% | -17.41% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,120.30% | -56.13% | -44.03% | 59.99% | 103.27% |
| Change in Net Operating Assets | 145.43% | -170.06% | 134.46% | -1,605.43% | 171.17% |
| Cash from Operations | -3.46% | -37.18% | 50.94% | 9.70% | 2.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 264.30% | -200.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 200.00% |
| Issuance of Common Stock | 27.58% | -- | -- | -99.29% | -84.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -40.67% | -423.72% | -- | -- | -100.00% |
| Cash from Financing | 60.92% | 828.97% | 9,423.53% | -99.31% | -84.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.89% | 501.66% | 70.75% | -24.02% | -199.30% |